Search results
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 7 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 4 days agoThis analysis aims to determine whether Moderna's stock is significantly overvalued by examining its current market performance and intrinsic value. Founded in 2010 and going ...
Quick takes: Moderna's RSV vaccine, flu-COVID combo vaccines, new polio cases
Center for Infectious Disease Research and Policy· 6 days agoThe FDA has pushed back its review of Moderna's RSV vaccine owing to administrative issues.
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 4 days agoFortunately, there are good reasons to believe the company has what it takes. Moderna is inching...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots |...
The State· 21 hours agoSince last week, hundreds of social media posts and news stories have claimed that AstraZeneca is removing its COVID vaccine from the market after admitting it caused blood ...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 1 day agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 20 hours agoThe review is now expected to be completed by the end of this month. The FDA, however, did not...